23 Hrs
Source:
وكالة الأنباء القطرية
Japanese scientists create esophageal cancer drug
Japan has begun to offer its first tumor-dissolving antiviral drug specifically designed to treat esophageal cancer, after receiving approval for use. The medication relies on engineered viruses that target cancer cells, replicate within them, and destroy them while preserving the surrounding tissues. Additionally, the drug helps stimulate the body's immune response to attack the tumor. The effects of the treatment are typically noticeable within a few weeks. It aims to treat a malignant tumor that develops in the lining of the esophagus, which obstructs swallowing and poses a life-threatening risk to the patient.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)